Mark your calendars—Parag More, Executive Director of Healthcare Analytics Solutions, will be presenting “How Lab Data Insights can Assist you in the Design and Execution of your Decentralized Trials” on September 29, 2021 during day 2 of DPharm. Click here to learn more about DPharm.
Lab data continues to play a critical role in the strategy, design, and execution of clinical trials. Patients’ diagnostic touchpoints at provider organizations and in community settings inherently provide the patient centricity that’s at the core of decentralized trials. Quest Diagnostics is playing an increasingly critical role in optimizing trials by using our proprietary lab data. The talk will explore the shifting dynamics of patient and provider engagement for decentralized trials and demonstrate how Quest Diagnostics is able to deploy engagement strategies for recruitment of clinically relevant participants. Discussion will also include how lab results and population insights help assess trial risks, analyze feasibility, and improve on the success metrics of decentralized trials.
DPHARM is the first event in the United States to question how we can disrupt the way clinical research gets done to reduce the burden to patients and physicians. DPHARM presented the first example of a decentralized clinical trial from Pfizer in 2011 and reports annually on the progress of flexible/decentralized trials with patient feedback.
Quest Clinical Trials Connect brings patient, physician, investigator, and other third-party data together to evaluate eligibility, enroll patients, and stay continually engaged through the clinical trial process.
Quest is proud to support DPharm as a corporate sponsor.